Weihai Baihe Biology Technological Co. Ltd.
Weihai Baihe Biology Technological Co., Ltd., together with its subsidiary, Weihai Lily Functional Food Technology Research Institute Limited Company, research, develops, manufactures, and sells nutrition and health food in China and internationally. The company offers health food; nutritious food for feminine glamour, male energy, elderly care, pregnancy, babies, and childcare, as well as nutrit… Read more
Market Cap & Net Worth: Weihai Baihe Biology Technological Co. Ltd. (603102)
Weihai Baihe Biology Technological Co. Ltd. (SHG:603102) has a market capitalization of $373.85 Million (CN¥2.74 Billion) as of March 19, 2026. Listed on the SHG stock exchange, this China-based company holds position #16517 globally and #4381 in its home market, demonstrating a 1.04% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Weihai Baihe Biology Technological Co. Ltd.'s stock price CN¥42.86 by its total outstanding shares 64000000 (64.00 Million).
Weihai Baihe Biology Technological Co. Ltd. Market Cap History: 2022 to 2026
Weihai Baihe Biology Technological Co. Ltd.'s market capitalization history from 2022 to 2026. Data shows change from $341.49 Million to $373.85 Million (-6.98% CAGR).
Weihai Baihe Biology Technological Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Weihai Baihe Biology Technological Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.38x
Weihai Baihe Biology Technological Co. Ltd.'s market cap is 0.38 times its annual revenue
0.14x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
2.20x
Weihai Baihe Biology Technological Co. Ltd.'s market cap is 2.20 times its annual earnings
5.51x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $341.49 Million | $725.33 Million | $137.84 Million | 0.47x | 2.48x |
| 2023 | $330.78 Million | $871.25 Million | $169.07 Million | 0.38x | 1.96x |
| 2024 | $306.16 Million | $801.40 Million | $139.31 Million | 0.38x | 2.20x |
Competitor Companies of 603102 by Market Capitalization
Companies near Weihai Baihe Biology Technological Co. Ltd. in the global market cap rankings as of March 19, 2026.
Key companies related to Weihai Baihe Biology Technological Co. Ltd. by market ranking:
- Nestle SA (PINK:NSRGF): Ranked #54 globally with a market cap of $258.19 Billion USD.
- Nestlé S.A. (SW:NESN): Ranked #69 globally with a market cap of $218.85 Billion USD ( CHF200.39 Billion CHF).
- Danone S.A (OTCQX:GPDNF): Ranked #435 globally with a market cap of $49.73 Billion USD.
- Danone SA (PA:BN): Ranked #465 globally with a market cap of $45.94 Billion USD ( €44.75 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #54 | Nestle SA | PINK:NSRGF | $258.19 Billion | $100.43 |
| #69 | Nestlé S.A. | SW:NESN | $218.85 Billion | CHF77.97 |
| #435 | Danone S.A | OTCQX:GPDNF | $49.73 Billion | $78.67 |
| #465 | Danone SA | PA:BN | $45.94 Billion | €70.78 |
Weihai Baihe Biology Technological Co. Ltd. Historical Marketcap From 2022 to 2026
Between 2022 and today, Weihai Baihe Biology Technological Co. Ltd.'s market cap moved from $341.49 Million to $ 373.85 Million, with a yearly change of -6.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥373.85 Million | -0.26% |
| 2025 | CN¥374.81 Million | +22.42% |
| 2024 | CN¥306.16 Million | -7.44% |
| 2023 | CN¥330.78 Million | -3.14% |
| 2022 | CN¥341.49 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Weihai Baihe Biology Technological Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $373.85 Million USD |
| MoneyControl | $373.85 Million USD |
| MarketWatch | $373.85 Million USD |
| marketcap.company | $373.85 Million USD |
| Reuters | $373.85 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.